Treatment Patterns and Adverse Event-Related Hospitalization Among Patients with Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non-small Cell Lung Cancer After Treatment with EGFR Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy Regimens-Reference-Cited by-同舟云学术

Treatment Patterns and Adverse Event-Related Hospitalization Among Patients with Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non-small Cell Lung Cancer After Treatment with EGFR Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy Regimens

Published:2023-09-02 Issue:4 Volume:10 Page:531-544
ISSN:2199-1154
Container-title:Drugs - Real World Outcomes
language:en
Short-container-title:Drugs - Real World Outcomes

Author:

Marrett Elizabeth,Kwong Winghan Jacqueline,Xie Jipan,Manceur Ameur M.,Sendhil Selvam R.,Wu Eric,Ionescu-Ittu Raluca,Subramanian Janakiraman

Funder

Daiichi-Sankyo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40801-023-00383-1.pdf

Reference51 articles.

1. World Health Organization. Global Cancer Observatory: cancer today. Lyon, France: International Agency for Research on Cancer. 2018. Available from: https://gco.iarc.fr/today. Accessed 27 Jan 2021.

2. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.

3. Mariotto AB, Robin Yabroff K, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103(2):117–28.

4. American Cancer Society. Non-small cell lung cancer. 2022. Available from: https://www.cancer.org/cancer/lung-cancer/about/what-is.html. Accessed 20 May 2022.

5. Lin J, Kamamia C, Brown D, et al. Survival among lung cancer patients in the US military health system: a comparison with the SEER population. Cancer Epidemiol Biomark Prev. 2018;27(6):673–9.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EGFR-Tyrosine Kinase Inhibitor Retreatment in Non-Small-Cell Lung Cancer Patients Previously Exposed to EGFR-TKI: A Systematic Review and Meta-Analysis;Journal of Personalized Medicine;2024-07-15